Finally, CH present at diagnosis was not associated with known risk factors for myeloma progression, including beta-2 microglobulin, lactate dehydrogenase (LDH), International Staging System (ISS) score, and high-risk cytogenetic abnormalities (Table 1). Here, B2M is linked to plasma cell myeloma.